<DOC>
	<DOCNO>NCT00941746</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability single intravenous dose PG110 , monoclonal antibody inhibit effect naturally occur substance , nerve growth factor ( NGF ) .</brief_summary>
	<brief_title>Safety Tolerability PG110 Patients With Knee Osteoarthritis Pain</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Moderate severe pain attribute knee osteoarthritis Significant comorbidity Significant pain state osteoarthritis Concomitant medication might affect assessment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>